The goal of this clinical trial is to evalute the efficacy of ALZGUARD, a smartphone-based digital therapeutic(DTx), in comparison to diagnosis by medical doctors, as weel as to assess the safety of the application.
Participants must be between 55 and 85 years old (both men and women).
Participants must be able to understand and voluntarily agree to the purpose, content, and procedures of the clinical trial.
Participants with no literacy or illiteracy.
Participants with an intellectual disability.
Participants with presenting active psychiatric symptoms.
Participants who have difficulty ALZGUARD application
HAII corp.ltd
Lead sponsor